Public Hearing: IRS Tight-Lipped On Industry Device Tax Concerns
This article was originally published in The Gray Sheet
Executive Summary
IRS remained mostly in listening mode during a recent public hearing on the impending device tax held at its headquarters in Washington, D.C.
You may also be interested in...
Device Tax Threatens Mobile App Developers; For Now, Though, Uncertainty Reigns
Questions about how the medical device tax could impact software application developers emerged at a June 20 American Enterprise Institute workshop.
FDA User Fee Reauthorization Charges Along With Senate Passage
FDA user fee and reform bill sails through Senate on 96-1 vote. House plans to take up its similar legislation this week.
Device Firms Seek More Exemptions, Pricing Flexibility For Oncoming Excise Tax
Written comments were due May 7 on the Internal Revenue Service’s proposed regulation to implement a 2.3% excise tax on device sales in the lead-up to a May 16 public hearing.